Latest Articles

‘How I knew I had endometrial cancer’: Survivors share their stories - UT MD Anderson

‘How I knew I had endometrial cancer’: Survivors share their stories UT MD Anderson

Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." - La Milano

Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." La Milano

The female reproductive tract microbiotas, inflammation, and gynecological conditions: mechanisms, therapeutic advances, and future perspectives.

The female reproductive tract (FRT), particularly the vagina, has traditionally been regarded as a sterile environment. However, it is now recognized that the vagina is a complex, dynamic ecosystem dominated …

Howard Stern's longtime cohost Robin Quivers announces she's cancer-free after 14 years: 'I get the chills' - MSN

Howard Stern's longtime cohost Robin Quivers announces she's cancer-free after 14 years: 'I get the chills' MSN

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - riauone.com

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 riauone.com

From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 - OncLive

From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 OncLive

Ovarian Cancer: The silent killer women don’t talk about - THIP Media

Ovarian Cancer: The silent killer women don’t talk about THIP Media

Regarding "Risk, prevalence and survival outcomes of ovarian cancer in women with endometriosis: the ENDOCANCER systematic review and meta-analysis".

Burden and Trends of Six Gynecological Diseases Among Chinese Women Aged 15-49 Years, 1990-2021: Evidence from GBD 2021.

This study examines the burden of six gynecological system diseases (uterine fibroids, polycystic ovarian syndrome, endometriosis, cervical cancer, ovarian cancer, and uterine cancer) in Chinese women aged 15-49 years from …

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - The Manila Times

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 The Manila Times